Unintentional injuries are the leading cause of death in young children. Get on Board with Child Safety is working with parents, caregivers, and consumers to make changes in the home and on the road to prevent these injuries.

Men with infertility and abnormal sperm counts have a 20-fold greater incidence of testicular cancer compared to the general population, according to a new study from the Department of Urology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The study, published in this month's issue of the Journal of Urology, may change clinical practice for male infertility and allow earlier diagnosis of testicular cancer.

NewYork-Presbyterian Hospital/Columbia University Medical Center is the first in the greater New York City-area to offer Vagus Nerve Stimulation (VNS) Therapy as a long-term treatment specifically approved by the FDA for treatment-resistant depression (TRD). VNS Therapy is approved as a long-term adjunctive (add-on) treatment for patients 18 years of age and older who are experiencing a major depressive episode and have not had an adequate response to four or more adequate antidepressant treatments. VNS Therapy was approved for the treatment of drug-resistant epilepsy in 1997, and is now the first treatment specifically studied and approved for TRD. Major depressive disorder is one of the most prevalent and serious illnesses in the U.S., affecting nearly 19 million Americans every year. Of those, one fifth, or approximately four million people, do not respond to multiple antidepressant treatments. For these people, psychotherapy, antidepressant medications, and even sometimes electroconvulsive therapy do not work, or only work for a short while and stop working over time. VNS Therapy is a newly approved treatment option for these people.

Phyllis Lantos has been named Executive Vice President at NewYork-Presbyterian Hospital. She also maintains the titles of Chief Financial Officer and Treasurer. In the new position, she will be responsible for all financial matters related to the Hospital, including financial reporting, financial planning, revenue cycle, budget, reimbursement, cost accounting, financing, insurance and managed care.

Using new approaches, an interdisciplinary team of scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City has gained a view of activity in key brain areas associated with a core difficulty in patients with borderline personality disorder -- shedding new light on this serious psychiatric condition.

Community preparedness for a bioterrorism attack or influenza outbreak has been the focus of much interest and effort in recent years. Now, public health experts at NewYork-Presbyterian Hospital/Weill Cornell Medical Center have developed a strategy for how hospitals can most efficiently inoculate their own staff with minimal disruption to patient care.

A 62-year-old New York City man is the first person to participate in a new clinical research trial at NewYork-Presbyterian Hospital/Columbia University Medical Center aimed at using patients' own stem cells to repair hearts damaged by chronic myocardial ischemia (CMI) - a severe form of coronary artery disease characterized by a shortage of blood supply to the heart; CMI is resistant to other treatments like angioplasty, stenting and bypass surgery.

Stem cells--popularly known as a source of biological rejuvenation--may play harmful roles in the body, specifically in the growth and spread of cancer. Amongst the wildly dividing cells of a tumor, scientists have located cancer stem cells. Physician-scientists from Weill Cornell Medical College are studying these cells with hopes of combating malignant cancers in the brain.